HER2 Mutation-Related Tumors, HER2, HER2-positive Breast Cancer,
Location: Boston MA, Lebanon NH, New York NY, New Brunswick NJ,
Sponsor: Iambic Therapeutics, Inc
Sex: All
Age: 18+
Code: NCT06253871
Phase1, Recruiting
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
for
Advanced Solid Tumors With KRAS G12C Mutations,
Location: Boston MA, Philadelphia PA, Fairfax VA, Detroit MI,
Sponsor: Frontier Medicines Corporation
Sex: All
Age: 18+
Code: NCT06244771
Phase1, Phase2, Recruiting
Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting
for
Lung Cancer Patients, Caregivers
Location: Bethesda MD
Sponsor: LUNGevity Foundation
Sex: All
Age: 18+
Code: NCT05826756
Recruiting
Cemiplimab and Fianlimab Before Surgery for the Treatment of Stage IB-IIIB Non-Small Cell Lung Cancer
for
Lung Non-Small Cell Carcinoma, Stage IB Lung Cancer AJCC v8,
Location: Rochester MN
Sponsor: Mayo Clinic
Sex: All
Age: 18+
Code: NCT06918132
Phase2, Recruiting
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
for
Metastatic Solid Tumor, Advanced Solid Tumor,
Location: Boston MA, New York NY, Fairfax VA, Miami FL,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT06561685
Phase1, Recruiting
Interested in new lung cancer trials?
Get alerts for new trials in your area by subscribing now
Imaging of T-cell Activation With [18F]F-AraG in Advanced Non Small Cell Lung Cancer
for
Non Small Cell Lung Cancer
Location: Stony Brook NY, Sacramento CA, Palo Alto CA
Sponsor: CellSight Technologies, Inc.
Sex: All
Age: 18+
Code: NCT04726215
Phase2, Recruiting
A Study of Stereotactic Radiosurgery (SRS) and Standard Treatment in People With Lung Cancer That Has Spread to the Brain
for
Non Small Cell Lung Cancer Metastatic
Location: Commack NY, Rockville Centre NY, Harrison NY,
Sponsor: Memorial Sloan Kettering Cancer Center
Sex: All
Age: 18+
Code: NCT06741085
Phase2, Recruiting
Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy
for
Lung Cancer
Location: New Brunswick NJ, Rochester NY, Columbia MO
Sponsor: Bo Lu
Sex: All
Age: 18+
Code: NCT06410300
Recruiting
Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers
for
Non-Small Cell Lung Cancer
Location: New York NY, Miami FL, Morgantown WV
Sponsor: Scientific Institute San Raffaele
Sex: All
Age: 18+
Code: NCT06626243
Recruiting
Feasibility of Evaluating Gene Alteration Analysis Using Samples Obtained by EBUS-TBNA in Patients With Lung Cancer
for
Lung Cancer
Location: Toronto
Sponsor: University Health Network, Toronto
Sex: All
Age: 18+
Code: NCT01487603
Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Neoadjuvant Chemo-Immunotherapy and Surgical Resection in Locally Advanced Non-small Cell Lung Cancer With N3 Lymph Node or Other High Risk Features
for
Non-small Cell Lung Cancer Stage III
Location: Washington D.C. DC, Charlottesville VA, St Louis MO
Sponsor: Georgetown University
Sex: All
Age: 18+
Code: NCT06449313
Phase2, Recruiting
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
for
Non-Small Cell Lung Cancer, Small Cell Lung Cancer,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT02146170
Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)